How Abbott Is Making Incremental Innovation Count For Patients

Abbott’s innovation and development center in Mumbai has made significant progress in shaping incremental but impactful innovations for India and some international markets. A once-daily formulation of heart failure drug ivabradine has caught the attention of the innovator company too.

Pillai_Raviraj
Abbott Executives Raviraj Pillai And Alexis Roberts-McIntosh

More from R&D

More from Scrip